32.08
+1.50
+(4.91%)
At close: February 18 at 4:00:01 PM EST
30.67
-1.40
(-4.38%)
After hours: 7:25:54 PM EST
Breakdown
TTM
12/31/2023
Operating Cash Flow
-76,977.00
-35,393.00
Investing Cash Flow
-38.00
-28,242.00
Financing Cash Flow
198,405.00
123,683.00
End Cash Position
187,329.00
75,195.00
Capital Expenditure
-38.00
-29.00
Issuance of Capital Stock
205,386.00
123,900.00
Free Cash Flow
-77,015.00
-35,422.00
12/31/2023 - 1/31/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MAZE Maze Therapeutics, Inc.
12.79
+6.58%
SION Sionna Therapeutics, Inc.
20.04
+0.05%
AARD Aardvark Therapeutics, Inc. Common Stock
13.56
+1.95%
SEPN Septerna, Inc.
6.87
-46.99%
BCAX Bicara Therapeutics Inc.
13.09
-2.89%
AAPG Ascentage Pharma Group Internat
18.51
+1.48%
NAMS NewAmsterdam Pharma Company N.V.
20.04
+0.65%
EWTX Edgewise Therapeutics, Inc.
26.13
+2.91%
BPMC Blueprint Medicines Corporation
92.48
-1.55%
RVMD Revolution Medicines, Inc.
41.47
+1.97%